Pfizer - Statistics & Facts

Pfizer Inc. is the world’s second largest pharmaceutical company in terms of prescription sales revenue. The New York City-based company generated some 53.6 billion U.S. dollars of total revenue in 2018. Based on net income, Pfizer is also at the top globally. As of August 2018, Pfizer had a market capitalization of around 240 billion U.S. dollars.

Pfizer manufactures some of the best-selling pharmaceutical products worldwide. Lipitor was Pfizer’s top drug for many years, but lost its patent in May 2012. Thus, Lipitor’s revenue decreased from around 10 billion U.S. dollars in 2011 to some 1.8 billion U.S. dollars in 2016. Other well-known drugs produced by Pfizer are Lyrica, Enbrel and Viagra. Until 2013, the company also had a notable animal health product line. Pfizer generates around half of its revenue within the United States.

As is common practice in the pharmaceutical industry, Pfizer spends a substantial part of its revenue on research and development. In 2018, the company’s R&D expenditure stood at some eight billion U.S. dollars, or around 15 percent of its total revenue. With over 92 thousand employees in 2018, Pfizer is also a significant employer all over the world.

Interesting statistics

In the following 5 chapters, you will quickly find the 22 most important statistics relating to "Pfizer".


Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!

Important key figures

The most important key figures provide you with a compact summary of the topic of "Pfizer" and take you straight to the corresponding statistics.


Selected top products

Expenditures and payments

Other key data

More interesting topics

Related topics

Other studies on the topic

Any more questions?

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.